デフォルト表紙
市場調査レポート
商品コード
1067214

マルチプレックスアッセイ(2022年~2030年):市場シェア、規模、動向、産業分析レポート、技術別、タイプ別、用途別、エンドユーザー別、地域別予測

Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Technology ; By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-Based Multiplex Assays); By Application, By End-User; By Regions; Segment Forecast, 2022 - 2030

出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
マルチプレックスアッセイ(2022年~2030年):市場シェア、規模、動向、産業分析レポート、技術別、タイプ別、用途別、エンドユーザー別、地域別予測
出版日: 2022年02月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマルチプレックスアッセイの市場規模は2030年までに55億7,000万米ドルになると予想されています。

当レポートでは世界のマルチプレックスアッセイ市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、技術別、タイプ別、用途別、エンドユーザー別、地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データ情報源
    • 一次情報源
    • 二次情報源

第4章 世界のマルチプレックスアッセイ市場:洞察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力(中)
    • 新規参入者の脅威(低)
    • 買い手の交渉力(中)
    • 代替の脅威(中)
    • 既存企業間の競争(高)
  • PESTLE分析
  • 業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のマルチプレックスアッセイ市場:用途別

  • 主な調査結果
  • イントロダクション
    • 用途別(2018年~2030年)
  • 研究開発
    • 研究開発別、地域別(2018年~2030年)
    • 創薬と開発
    • バイオマーカーの発見と検証
  • 臨床診断
    • 臨床診断別、地域別(2018年~2030年)
    • がん
    • 心血管疾患
    • 自己免疫疾患
    • 神経系障害
    • 代謝および内分泌障害
    • その他

第6章 世界のマルチプレックスアッセイ市場:タイプ別

  • 主な調査結果
  • イントロダクション
    • タイプ別(2018年~2030年)
  • タンパク質マルチプレックスアッセイ
    • タンパク質マルチプレックスアッセイ別、地域別(2018年~2030年)
    • 平面タンパク質アッセイ
    • ビーズベースタンパク質アッセイ
    • その他
  • 核酸マルチプレックスアッセイ
    • 核酸マルチプレックスアッセイ別、地域別(2018年~2030年)
    • 平面核酸アッセイ
    • ビーズベース核酸アッセイ
    • その他
  • セルベースマルチプレックスアッセイ
    • セルベースマルチプレックスアッセイ別、地域別(2018年~2030年)

第7章 世界のマルチプレックスアッセイ市場:技術別

  • 主な調査結果
  • イントロダクション
    • 技術別(2018年~2030年)
  • フローサイトメトリー
    • フローサイトメトリー別、地域別(2018年~2030年)
  • 蛍光検出
    • 蛍光検出別、地域別(2018年~2030年)
  • 発光
    • 発光別、地域別(2018年~2030年)
  • マルチプレックスリアルタイムPCR
    • マルチプレックスリアルタイムPCR別、地域別(2018年~2030年)
  • その他
    • その他別、地域別(2018年~2030年)

第8章 世界のマルチプレックスアッセイ市場:エンドユーザー別

  • 主な調査結果
  • イントロダクション
    • エンドユーザー別(2018年~2030年)
  • 製薬およびバイオ技術企業
    • 製薬およびバイオ技術企業別、地域別(2018年~2030年)
  • 病院および研究機関
    • 病院および研究機関別、地域別、2018年~2030年(10億米ドル)
  • 紹介検査所
    • 紹介検査所別、地域別(2018年~2030年)
  • その他
    • その他別、地域別(2018年~2030年)

第9章 世界のマルチプレックスアッセイ市場:地域別

  • 主な調査結果
  • イントロダクション
    • 地域別(2018年~2030年)
  • 北米
    • 用途別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 米国
    • カナダ
  • 欧州
    • 用途別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • オーストリア
  • アジア太平洋地域
    • 用途別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 用途別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • サウジアラビア
    • 南アフリカ
    • イスラエル
    • アラブ首長国連邦
  • ラテンアメリカ
    • 用途別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 競合情勢

  • 拡張および取得分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第11章 企業プロファイル

  • Luminex Corporation
  • Enzo Life Sciences, Inc.
  • Promega Corporation
  • Meso Scale Diagnostics
  • Quanterix
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V
  • Illumina, Inc.
  • Shimadzu Biotech
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Becton
  • AYOXXA Biosystems GmbH
  • Bio-Techne Corporation
  • Dickinson and Company
  • Randox Laboratories
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Olink
  • DiaSorin S.p.A.
  • Antigenix America, Inc
  • Siemens Healthineers
  • PerkinElmer, Inc
  • Boster Biological Technology
  • Seegene
  • Cayman Chemical Company
図表

List of Tables

  • Table 1 Global Multiplex Assays Market, by Application, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Multiplex Assays Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Multiplex Assays Market, by Technology, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Multiplex Assays Market, by End-User, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Multiplex Assays Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 7 North America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 8 North America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 9 North America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 26 France: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 27 France: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 28 France: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 29 France: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 30 UK: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 31 UK: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 32 UK: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 33 UK: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 46 Austria: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 47 Austria: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 48 Austria: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 49 Austria: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 54 China: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 55 China: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 56 China: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 57 China: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 62 India: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 63 India: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 64 India: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 65 India: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 110 Isreal: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • Table 111 Isreal: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • Table 112 Isreal: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 113 Isreal: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Multiplex Assays Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up End-User

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Application

Figure 7. Global Multiplex Assays Market, by Application, 2021 & 2030 (USD Billion)

Figure 8. Market by End-User

Figure 9. Global Multiplex Assays Market, by End-User, 2021 & 2030 (USD Billion)

Figure 10. Market by Type

Figure 11. Global Multiplex Assays Market, by Type, 2021 & 2030 (USD Billion)

Figure 12. Market by Technology

Figure 13. Global Multiplex Assays Market, by Technology, 2021 & 2030 (USD Billion)

Figure 14. Multiplex Assays Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Multiplex Assays Market

目次
Product Code: PM2299

The global multiplex assays market size is expected to reach USD 5.57 billion by 2030, according to a new study by Polaris Market Research. The report "Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Technology; By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-Based Multiplex Assays); By Application, By End-User; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The key factors driving the market's growth include adopting multiplex assays across various verticals such as health services and others. Due to the growing use of customized treatment and benefits over standard tests, the market is expected to rise rapidly. Medical science, which has gained popularity in recent years, strives to provide individual patients with tailored therapies based on the molecular foundation of their disease.

Based on the type, the nucleic acid segment accounted for the leading share in the industry in 2021. This is due to the rising use of nucleic acids, ease of configuration to detect practically any target, low sample volume requirements, and level of automation to be achieved. A rise in the use of molecular diagnostic tests developed to diagnose diseases, such as human genetic markers, such as cancer, and genetic markers for disease predisposition also contributes to the economic development of the nucleic acid-based segment.

Market players such as Luminex Corporation, Enzo Life Sciences, Inc., Promega Corporation, Meso Scale Diagnostics, Quanterix, Thermo Fisher Scientific Inc., Qiagen N.V., Illumina, Inc, Shimadzu Biotech, Abcam plc, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Randox Laboratories, Merck KGaA, Agilent Technologies, Inc., Olink, DiaSorin S.p.A., Antigenix America, Inc., Siemens Healthineers, PerkinElmer, Inc., Boster Biological Technology, Seegene, and Cayman Chemical Company are some key players operating in the global market.

In August 2021, The BD COR System, a new automated diagnostic system from Becton, Dickinson, and Company, was released. In centralized laboratories across the U.S., the system uses robots and sample management software algorithms for genetic disease testing. Thus, the development of new technologies by major players and adoption of them across various laboratories is boosting the market growth during the forecast period.

Polaris Market Research has segmented the multiplex assays market report based on type, technology, application, end-user, and region:

Multiplex assays, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Protein

Planar Protein

Bead-Based Protein

Other Protein

Nucleic Acid

Planar Nucleic Acid

Bead-Based Nucleic Acid

Other Nucleic Acid

Cell-Based

Multiplex assays, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

Flow Cytometry

Fluorescence Detection

Luminescence

Multiplex Real-Time PCR

Other Technologies

Multiplex assays, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Research & Development

Drug Discovery & Development

Biomarker Discovery & Validation

Clinical Diagnostics

Infectious Diseases

Cancer

Cardiovascular Diseases

Autoimmune Diseases

Nervous System Disorders

Metabolism & Endocrinology Disorders

Others

Multiplex assays, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceutical & Biotechnology Companies

Hospitals & Research Institutes

Reference Laboratories

Others

Multiplex assays, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Multiplex Assays Market Insights

  • 4.1. Multiplex Assays - Industry Snapshot
  • 4.2. Multiplex Assays Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of multiplex assays in companion diagnostics
      • 4.2.1.2. Increasing validation of the biomarkers in molecular and protein diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Increasing cost of the equipment and increasingly stringent regulation and standards
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Multiplex Assays Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Multiplex Assays Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
  • 5.3. Research & Development
    • 5.3.1. Global Multiplex Assays Market, by Research & Development, by Region, 2018 - 2030 (USD Billion)
    • 5.3.2. Drug Discovery & Development
      • 5.3.2.1. Global Multiplex Assays Market, by Drug Discovery & Development, by Region, 2018 - 2030 (USD Billion)
    • 5.3.3. Biomarker Discovery & Validation
      • 5.3.3.1. Global Multiplex Assays Market, by Biomarker Discovery & Validation, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Clinical Diagnostics
    • 5.4.1. Global Multiplex Assays Market, by Clinical Diagnostics, by Region, 2018 - 2030 (USD Billion)
    • 5.4.2. Cancer
      • 5.4.2.1. Global Multiplex Assays Market, by Cancer, by Region, 2018 - 2030 (USD Billion)
    • 5.4.3. Cardiovascular Diseases
      • 5.4.3.1. Global Multiplex Assays Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Billion)
    • 5.4.4. Autoimmune Diseases
      • 5.4.4.1. Global Multiplex Assays Market, by Autoimmune Diseases, by Region, 2018 - 2030 (USD Billion)
    • 5.4.5. Nervous System Disorders
      • 5.4.5.1. Global Multiplex Assays Market, by Nervous System Disorders, by Region, 2018 - 2030 (USD Billion)
    • 5.4.6. Metabolism & Endocrinology Disorders
      • 5.4.6.1. Global Multiplex Assays Market, by Metabolism & Endocrinology Disorders, by Region, 2018 - 2030 (USD Billion)
    • 5.4.7. Others
      • 5.4.7.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)

6. Global Multiplex Assays Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
  • 6.3. Protein Multiplex Assays
    • 6.3.1. Global Multiplex Assays Market, by Protein Multiplex Assays, by Region, 2018 - 2030 (USD Billion)
    • 6.3.2. Planar Protein Assays
      • 6.3.2.1. Global Multiplex Assays Market, by Planar Protein Assays, by Region, 2018 - 2030 (USD Billion)
    • 6.3.3. Bead-Based Protein Assays
      • 6.3.3.1. Global Multiplex Assays Market, by Bead-Based Protein Assays, by Region, 2018 - 2030 (USD Billion)
    • 6.3.4. Other Protein Assays
      • 6.3.4.1. Global Multiplex Assays Market, by Other Protein Assays, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Nucleic Acid Multiplex Assays
    • 6.4.1. Global Multiplex Assays Market, by Nucleic Acid Multiplex Assays, by Region, 2018 - 2030 (USD Billion)
    • 6.4.2. Planar Nucleic Acid Assays
      • 6.4.2.1. Global Multiplex Assays Market, by Planar Nucleic Acid Assays, by Region, 2018 - 2030 (USD Billion)
    • 6.4.3. Bead-Based Nucleic Acid Assays
      • 6.4.3.1. Global Multiplex Assays Market, by Bead-Based Nucleic Acid Assay, by Region, 2018 - 2030 (USD Billion)
    • 6.4.4. Other Nucleic Acid Assays
      • 6.4.4.1. Global Multiplex Assays Market, by Other Nucleic Acid Assays, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Cell-Based Multiplex Assays
    • 6.5.1. Global Multiplex Assays Market, by Cell-Based Multiplex Assays, by Region, 2018 - 2030 (USD Billion)

7. Global Multiplex Assays Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • 7.3. Flow Cytometry
    • 7.3.1. Global Multiplex Assays Market, by Flow Cytometry, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Fluorescence Detection
    • 7.4.1. Global Multiplex Assays Market, by Fluorescence Detection, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Luminescence
    • 7.5.1. Global Multiplex Assays Market, by Luminescence, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Multiplex Real-Time PCR
    • 7.6.1. Global Multiplex Assays Market, by Multiplex Real-Time PCR, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Multiplex Assays Market, by End-User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Multiplex Assays Market, by Pharmaceutical & Biotechnology Companies, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Hospitals & Research Institutes
    • 8.4.1. Global Multiplex Assays Market, by Hospitals & Research Institutes, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Reference Laboratories
    • 8.5.1. Global Multiplex Assays Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)

9. Global Multiplex Assays Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Multiplex Assays Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Multiplex Assays Market - North America
    • 9.3.1. North America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.5. Multiplex Assays Market - U.S.
      • 9.3.5.1. U.S.: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.6. Multiplex Assays Market - Canada
      • 9.3.6.1. Canada: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4. Multiplex Assays Market - Europe
    • 9.4.1. Europe: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.5. Multiplex Assays Market - UK
      • 9.4.5.1. UK: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.6. Multiplex Assays Market - France
      • 9.4.6.1. France: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.7. Multiplex Assays Market - Germany
      • 9.4.7.1. Germany: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.8. Multiplex Assays Market - Italy
      • 9.4.8.1. Italy: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.9. Multiplex Assays Market - Spain
      • 9.4.9.1. Spain: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.10. Multiplex Assays Market - Netherlands
      • 9.4.10.1. Netherlands: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.11. Multiplex Assays Market - Austria
      • 9.4.11.1. Austria: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Austria.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Austria: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Austria: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5. Multiplex Assays Market - Asia Pacific
    • 9.5.1. Asia Pacific: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.5. Multiplex Assays Market - China
      • 9.5.5.1. China: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.6. Multiplex Assays Market - India
      • 9.5.6.1. India: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.7. Multiplex Assays Market - Japan
      • 9.5.7.1. Japan: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.8. Multiplex Assays Market - Malaysia
      • 9.5.8.1. Malaysia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.9. Multiplex Assays Market - Indonesia
      • 9.5.9.1. Indonesia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.10. Multiplex Assays Market - South Korea
      • 9.5.10.1. South Korea: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6. Multiplex Assays Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.5. Multiplex Assays Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.6. Multiplex Assays Market - South Africa
      • 9.6.6.1. South Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.7. Multiplex Assays Market - Israel
      • 9.6.7.1. Israel: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.8. Multiplex Assays Market - UAE
      • 9.6.8.1. UAE: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7. Multiplex Assays Market - Latin America
    • 9.7.1. Latin America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.5. Multiplex Assays Market - Mexico
      • 9.7.5.1. Mexico: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.6. Multiplex Assays Market - Brazil
      • 9.7.6.1. Brazil: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.7. Multiplex Assays Market - Argentina
      • 9.7.7.1. Argentina: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Luminex Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Enzo Life Sciences, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Promega Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Meso Scale Diagnostics
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Quanterix
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Thermo Fisher Scientific Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Qiagen N.V
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Illumina, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Shimadzu Biotech
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Abcam plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Bio-Rad Laboratories, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Becton
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. AYOXXA Biosystems GmbH
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Bio-Techne Corporation
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Dickinson and Company
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Randox Laboratories
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Merck KGaA
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Agilent Technologies, Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Olink
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development
  • 11.20. DiaSorin S.p.A.
    • 11.20.1. Company Overview
    • 11.20.2. Financial Performance
    • 11.20.3. Product Benchmarking
    • 11.20.4. Recent Development
  • 11.21. Antigenix America, Inc
    • 11.21.1. Company Overview
    • 11.21.2. Financial Performance
    • 11.21.3. Product Benchmarking
    • 11.21.4. Recent Development
  • 11.22. Siemens Healthineers
    • 11.22.1. Company Overview
    • 11.22.2. Financial Performance
    • 11.22.3. Product Benchmarking
    • 11.22.4. Recent Development
  • 11.23. PerkinElmer, Inc
    • 11.23.1. Company Overview
    • 11.23.2. Financial Performance
    • 11.23.3. Product Benchmarking
    • 11.23.4. Recent Development
  • 11.24. Boster Biological Technology
    • 11.24.1. Company Overview
    • 11.24.2. Financial Performance
    • 11.24.3. Product Benchmarking
    • 11.24.4. Recent Development
  • 11.25. Seegene
    • 11.25.1. Company Overview
    • 11.25.2. Financial Performance
    • 11.25.3. Product Benchmarking
    • 11.25.4. Recent Development
  • 11.26. Cayman Chemical Company
    • 11.26.1. Company Overview
    • 11.26.2. Financial Performance
    • 11.26.3. Product Benchmarking
    • 11.26.4. Recent Development